Howlader N, Noone A, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis D (2019) SEER cancer statistics review, 1975–2016, National Cancer Institute. Bethesda, MD 2020:1–10

Google Scholar 

Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416

Article  CAS  PubMed  Google Scholar 

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130

Article  CAS  PubMed  PubMed Central  Google Scholar 

Childers CP, Childers KK, Maggard-Gibbons M, Macinko J (2017) National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol 35(34):3800–3806

Article  PubMed  PubMed Central  Google Scholar 

Obstetricians ACo, Gynecologists, Practice CoG (2018) Cascade testing: testing women for known hereditary genetic mutations associated with cancer. ACOG committee opinion no. 727. Obstet Gynecol Surv 73(4):211–212

Article  Google Scholar 

Caswell-Jin JL, Zimmer AD, Stedden W, Kingham KE, Zhou AY, Kurian AW (2019) Cascade genetic testing of relatives for hereditary cancer risk: results of an online initiative. J Natl Cancer Inst 111(1):95–98

Article  PubMed  Google Scholar 

Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC (2020) Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet 28(12):1631–1644

Article  PubMed  PubMed Central  Google Scholar 

Makhnoon S, Tran G, Levin B, Mattie KD, Dreyer B, Volk RJ, Grana G, Arun BK, Peterson SK (2021) Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes. Cancer 127(19):3605–3613

Article  CAS  PubMed  Google Scholar 

Trottier M, Lunn J, Butler R, Curling D, Turnquest T, Royer R, Akbari MR, Donenberg T, Hurley J, Narod SA (2015) Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas. Clin Genet 88(2):182–186

Article  CAS  PubMed  Google Scholar 

Baroutsou V, Underhill-Blazey ML, Appenzeller-Herzog C, Katapodi MC (2021) Interventions facilitating family communication of genetic testing results and cascade screening in hereditary breast/ovarian cancer or lynch syndrome: a systematic review and meta-analysis. Cancers (Basel) 13(4):925

Article  PubMed  Google Scholar 

Katz SJ, Kurian AW, Morrow M (2015) Treatment decision making and genetic testing for breast cancer: mainstreaming mutations. JAMA 314(10):997–998

Article  CAS  PubMed  Google Scholar 

van den Marleen Heuvel L, Stemkens D, van Zelst-Stams WAG, Willeboordse F, Christiaans I (2020) How to inform at-risk relatives? attitudes of 1379 dutch patients, relatives, and members of the general population. J Genet Couns 29(5):786–799

Article  Google Scholar 

Sanz J, Ramón y Cajal T, Torres A, Darder E, Gadea N, Velasco A, Fortuny D, López C, Fisas D, Brunet J et al (2010) Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern spain. Fam Cancer 9(3):297–304

Article  PubMed  Google Scholar 

Sermijn E, Delesie L, Deschepper E, Pauwels I, Bonduelle M, Teugels E, De Grève J (2016) The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. Fam Cancer 15(2):155–162

Article  PubMed  PubMed Central  Google Scholar 

Menko FH, Aalfs CM, Henneman L, Stol Y, Wijdenes M, Otten E, Ploegmakers MM, Legemaate J, Smets EM, de Wert GM et al (2013) Informing family members of individuals with lynch syndrome: a guideline for clinical geneticists. Fam Cancer 12(2):319–324

Article  PubMed  Google Scholar 

Peters M, Godfrey C, McInerney P, Soares C, Khalil H, Parker D (2015) The joanna briggs institute reviewers’ manual 2015: methodology for jbi scoping reviews. The Joanna Briggs Institute, Adelaide, SA Australia

Google Scholar 

Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8(1):19–32

Article  Google Scholar 

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467–473

Article  PubMed  Google Scholar 

Oxford English Dictionary. Oxford University Press. Dictionary on line: https://www.oed.com/search/dictionary/?scope=Entries&q=psychosocial. Retrieved December 5 2023.

Hong QN, Pluye P, Bujold M, Wassef M (2017) Convergent and sequential synthesis designs: implications for conducting and reporting systematic reviews of qualitative and quantitative evidence. Syst Rev 6(1):61

Article  PubMed  PubMed Central  Google Scholar 

Critical Appraisal Skills Programme (Qualitative) Checklist [https://www.unisa.edu.au/contentassets/72bf75606a2b4abcaf7f17404af374ad/7a-casp-qualitative-cat.pdf]

Service HIRA (2013) Revision of study design algorithm tool and bias risk assessment tool. Health Insurance Review & Assessment Service, Seoul

Google Scholar 

Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, Jang BH, Son HJ (2013) Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 66(4):408–414

Article  PubMed  Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898

Article  PubMed  Google Scholar 

Hong QN, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon M-P, Griffiths F, Nicolau B, O’Cathain A (2018) The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers. Educ Inf 34(4):285–291

Google Scholar 

Alegre N, Perre PV, Bignon YJ, Michel A, Galibert V, Mophawe O, Corsini C, Coupier I, Chiesa J, Robert L et al (2019) Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations. Psychooncology 28(8):1679–1686

Article  PubMed  Google Scholar 

Battistuzzi L, Franiuk M, Kasparian N, Rania N, Migliorini L, Varesco L (2019) A qualitative study on decision-making about BRCA1/2 testing in Italian women. Eur J Cancer Care (Engl) 28(5):e13083

Article  PubMed  Google Scholar 

Cragun D, Weidner A, Tezak A, Clouse K, Pal T (2021) Family communication of genetic test results among women with inherited breast cancer genes. J Genet Couns 30(3):701–709

Article  CAS  PubMed  Google Scholar 

Daly MB, Montgomery S, Bingler R, Ruth K (2016) Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study. Fam Cancer 15(4):697–706

Article  PubMed  PubMed Central  Google Scholar 

Dean M, Tezak AL, Johnson S, Pierce JK, Weidner A, Clouse K, Pal T, Cragun D (2021) Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers. Patient Educ Couns 104(4):720–725

Article  PubMed  PubMed Central  Google Scholar 

Dwyer AA, Hesse-Biber S, Shea H, Zeng Z, Yi S (2022) Coping response and family communication of cancer risk in men harboring a BRCA mutation: a mixed methods study. Psychooncology 31(3):486–495

Article  PubMed  Google Scholar 

Dwyer AA, Hesse-Biber S, Flynn B, Remick S (2020) Parent of origin effects on family communication of risk in BRCA+ women: a qualitative investigation of human factors in cascade screening. Cancers (Basel) 12(8):2316

Article  CAS  PubMed  Google Scholar 

Elrick A, Ashida S, Ivanovich J, Lyons S, Biesecker BB, Goodman MS, Kaphingst KA (2017) Psychosocial and clinical factors associated with family communication of cancer genetic test results among women diagnosed with breast cancer at a young age. J Genet Couns 26(1):173–181

Article  PubMed  Google Scholar 

Fehniger J, Lin F, Beattie MS, Joseph G, Kaplan C (2013) Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers. J Genet Couns 22(5):603–612

Article  PubMed  Google Scholar 

Hesse-Biber S, Dwyer AA, Yi S (2020) Parent of origin differences in psychosocial burden and approach to BRCA risk management. Breast J 26(4):734–738

Article  PubMed  Google Scholar 

Hoskins LM, Werner-Lin A (2013) A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18–25. J Genet Couns 22(1):27–38

Article  PubMed  Google Scholar 

Katapodi MC, Ming C, Northouse LL, Duffy SA, Duquette D, Mendelsohn-Victor KE, Milliron KJ, Merajver SD, Dinov ID, Janz NK (2020) Genetic testing and surveillance of young breast cancer survivors and blood relatives: a cluster randomized trial. Cancers (Basel) 12(9):2526

Article  CAS  PubMed  Google Scholar 

Katapodi MC, Northouse LL, Milliron KJ, Liu G, Merajver SD (2013) Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families. Psychooncology 22(6):1336–1343

Article  PubMed  Google Scholar 

Lafrenière D, Bouchard K, Godard B, Simard J, Dorval M (2013) Family communication following BRCA1/2 genetic testing: a close look at the process. J Genet Couns 22(3):323–335

Article  PubMed  Google Scholar 

Lee DS, Meiser B, Mariapun S, Hassan T, Yip CH, Mohd Taib NA, Teo SH, Thong MK, Yoon SY (2021) Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse asian setting. J Genet Couns 30(3):720–729

Article  CAS  PubMed